Jianming Ying

Jianming Ying

Department of Pathology, Chinese Academy of Medical Sciences and Peking Union Medical College

Affiliated withChinese Academy of Medical Sciences and Peking Union Medical College

Research Area

Biography

Jianming Ying has not added Biography.
If you are Jianming Ying and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Publication title
2025

Other Publications

Article
Year
ARID2: a new tumor suppressor gene in hepatocellular carcinoma.

Oncotarget| PubMed ID: 22095441

2011
2014
2015
2015
2016
Icotinib in Patients with Pretreated Advanced Esophageal Squamous Cell Carcinoma with EGFR Overexpression or EGFR Gene Amplification: A Single-Arm, Multicenter Phase 2 Study.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 26980473

2016
2016
2016
2016
Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib Treatment.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 27614248

2017
2016
2017
2017
2017
2017
2017
2017
2017
2017
2017
2018
2018
2017
2018
2018
2018
2021
2018
Sequencing a super multiple synchronous lung cancer reveals a novel variant in driver gene ARID1B.

The Journal of thoracic and cardiovascular surgery| PubMed ID: 29576263

2018
Classic SRY-box protein SOX7 functions as a tumor suppressor regulating WNT signaling and is methylated in renal cell carcinoma.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 29957056

2019
2018
Clinicopathological features and surgical outcomes of four rare subtypes of primary liver carcinoma.

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu| PubMed ID: 30046230

2018
Self-Assembled Nanomedicines for Anticancer and Antibacterial Applications.

Advanced healthcare materials| PubMed ID: 30080319

2018
2018
2019
2019
2018
Concurrent Presence of ALK Rearrangement and MET Mutation in Lung Adenocarcinoma.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 30683300

2019
2019
2019
[Review on Treatment Modalities for Resectable IIIa/N2 Non-small Cell Lung Cancer].

Zhongguo fei ai za zhi = Chinese journal of lung cancer| PubMed ID: 30827328

2019
2019
2019
2019
2019
2019
2019
P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs.

Journal of experimental & clinical cancer research : CR| PubMed ID: 31455383

2019
2020
2018
2020
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 32036071

2020
2020
Intergenic Breakpoints Identified by DNA Sequencing Confound Targetable Kinase Fusion Detection in NSCLC.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 32151779

2020
2020
2020
2020
2020
2020
2020
2020
2020
PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation.

Journal of experimental & clinical cancer research : CR| PubMed ID: 32746883

2020
2020
2020
2020
2020
2020
Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody-Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 33109737

2021
2021
2021
2021
Potential Unreliability of Uncommon ALK, ROS1, and RET Genomic Breakpoints in Predicting the Efficacy of Targeted Therapy in NSCLC.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 33248323

2021
2020
Necrosis Is Not the Main Part of Immune-Related Pathologic Response to Neoadjuvant Immunotherapy in Squamous Cell Lung Cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 33384061

2021
2020
2021
Tumor-Associated Stromal Cellular Density as a Predictor of Recurrence and Mortality in Breast Cancer: Results from Ethnically Diverse Study Populations.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology| PubMed ID: 33952648

2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2021
2022
2021
2020
2022
2021
2019
Sclerosing thymoma: a case report and literature review.

Translational cancer research| PubMed ID: 35117663

2020
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
2022
Expert consensus on perioperative treatment for non-small cell lung cancer.

Translational lung cancer research| PubMed ID: 35958323

2022
2022
2022
2022
2022
2022
2022
2023
2022
2023
2022
2023
Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With Resectable NSCLC: A Phase 2 Clinical Trial.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 36870519

2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2023
2024
2023
2023
2024
2023
Gastric tubular adenocarcinoma with diffuse neutrophils infiltrating: characteristics and probable treatment strategy.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association| PubMed ID: 38019350

2024
2023
CD74/SLC34A2-ROS1 Fusion Variants Involving the Transmembrane Region Predict Poor Response to Crizotinib in NSCLC Independent of TP53 Mutations.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer| PubMed ID: 38070598

2024
2022
2023
2024
2024
2024
2024
2025
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2024
2023
2021
2023
2021
2024
2024
2024
2024
2024
2025
2024
2025
2025
2025
2025
2025
2025
2025
2025
2025
2025
2025
2025
2025
2025
2025
2025
2025
2025
2025
2025